缩宫素和米索前列醇预防产后出血的临床效果对比分析

Comparative Analysis of the Clinical Effect of Oxytocin and Misoprostol in Preventing Postpartum Hemorrhage

目的探讨针对医院产妇，观察选择缩宫素＋米索前列醇在预防产后出血方面获得的效果。方法选取我院2012年2月～2015年2月产妇60例。平均分成两组，C1组（观察组30例）：临床选择缩宫素＋米索前列醇预防产后出血；C2组（对照组30例）：临床选择缩宫素预防产后出血。对比两组产妇在产后2h出血量、产后出血率、第三产程时间以及产后24h出血量几方面表现的差异。结果两组产妇分别完成临床治疗后，在产后出血量、第三产程时间、产后2h出血量以及产后24h出血量几方面．C1组优于C2组产妇（P〈0.05）：在不良反应发生率方面，C1组与C2组产妇未表现出显著差异（P〉0．05）。结论针对产妇，临床选择米索前列醇＋缩宫素进行治疗，针对产后出血能够发挥预防效果，将产妇产后出血量有效降低，将出现不良反应的概率有效降低，凸显两种药物预防产后出血的临床价值。

Objective To investigate the maternity hospital for observation selection effect of oxytocin and misoprostol in preventing postpartum hemorrhage obtained. Methods 60 Gases were chosen in our hospital in February 2012 - February 2015. Were divided into two groups, C1 group （observation group, 30 cases）： clinical selection of oxytocin and misoprostol. C2 group （30 patients）： clinical selection of oxytocin to prevent postpartum hemorrhage. Compared two groups of women at 2 h post-partum bleeding, postpartum hemorrhage, and the third stage of labor and postpartum hemorrhage 24 h several aspects of performance differences. Results The two groups of mothers were completed clinical treatment, postpartum hemorrhage, and the third stage of labor, postpartum hemorrhage 2 h and 24 h post-partum hemorrhage aspects, C1 C2 group was superior to women （P〈0.05）, the adverse reactions incidence, C1 and C2 groups were group showed no significant difference （P〉0.05）. Conclusion For women, clinical choose misoprostol and oxytocin treatment for postpartum hemorrhage can play a preventive effect, will reduce the amount of postpartum hemorrhage, the probability of adverse effects will occur effectively reduce the highlights of the two drugs to prevent postpartum hemorrhage.